<p>&quot;As I leave my competition respirator style, climb the ladder to success escalator style.&quot; Today we have the Jaegercast, but first we continue our discussion about apabetalone, a new candidate drug for FSHD.</p>

CRISPR in the clinic

MyFSHD is about education and personal empowerment for the worldwide facioscapulohumeral muscular dystrophy (FSHD) community. Here we have discussions and commentary hosted by FSHD researcher Peter Jones, PhD, on many things of interest to the FSHD community. Learn about the science behind the different FSHD therapeutic approaches, FSHD pathology, family genetics and FSHD diagnostics. We will discuss upcoming clinical trials and what to look forward to. You will get to understand how you can be better prepared, become involved, and help contribute to defeating FSHD once and for all.